Statements (49)
Predicate | Object |
---|---|
gptkbp:instanceOf |
business group
|
gptkbp:acquisition |
multiple biotech firms
|
gptkbp:areaServed |
global
|
gptkbp:CEO |
gptkb:Adar_Poonawalla
|
gptkbp:employees |
over 5000
|
gptkbp:foundedBy |
gptkb:Cyrus_Poonawalla
|
gptkbp:headquarters |
gptkb:Pune,_India
|
https://www.w3.org/2000/01/rdf-schema#label |
Poonawalla Group
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:keyPeople |
gptkb:Cyrus_Poonawalla
gptkb:Adar_Poonawalla |
gptkbp:location |
gptkb:India
|
gptkbp:notableEvent |
sustainability initiatives
community engagement programs investment in research and development collaboration with universities support for public health campaigns expansion into international markets support for education initiatives support for healthcare initiatives collaboration with governments response to health emergencies commitment to quality control COVID-19 vaccine production advancement of public health policies advocacy for vaccination awareness awards for innovation in vaccines contribution to global vaccination efforts contribution to immunization programs development of affordable vaccines development of new vaccine technologies investment in healthcare infrastructure largest vaccine producer in the world leadership in vaccine distribution recognition in global health forums supply of vaccines to over 170 countries partnership_with_AstraZeneca partnership_with_Gavi partnership_with_Novavax |
gptkbp:notableFeature |
gptkb:Serum_Institute_of_India
|
gptkbp:parentOrganization |
gptkb:Poonawalla_Group_Holdings
|
gptkbp:partnerships |
various global health organizations
|
gptkbp:philanthropy |
gptkb:Poonawalla_Foundation
|
gptkbp:products |
vaccines
biologicals |
gptkbp:revenue |
over $1 billion
|
gptkbp:type |
private company
|
gptkbp:website |
www.poonawallagroup.com
|
gptkbp:yearEstablished |
1966
|